GNPX - Genprex, Inc.
IEX Last Trade
0.78
0.002 0.295%
Share volume: 249,319
Last Updated: Fri 10 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$0.78
0.01
0.01%
Summary score
5%
Profitability
0%
Dept financing
11%
Liquidity
39%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.84%
Return on assets
-58.69%
Return on sales
0%
Return on invested capital
-1243.24%
Total debt ratio
29.55%
Debt ratio change over timeo
-1.02%
Current Ratio
34.68%
Quick Ratio
97.02%
Cash Position Ratio
31.7%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-79.2%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
43.85%
Debt ratio change over timeo
-1.04%
Current Ratio
1.64%
Quick Ratio
0%
Cash Position Ratio
1.41%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-47.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
30.31%
Debt ratio change over time
-1.02%
Current Ratio
2.42%
Quick Ratio
0%
Cash Position Ratio
2.16%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-100.28%
Return on assets
-95.85%
Return on sales
0%
Return on invested capital
-119.84%
Total debt ratio
-102.35%
Debt ratio change over time
-1.02%
Current Ratio
-0.55%
Quick Ratio
0.55%
Cash Position Ratio
-0.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | GNPX | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | -17.84% | 13.03% | 18.15% | 6.63% |
Return on assets | -58.69% | 2.28% | 3.22% | 5.84% |
Return on sales | 0% | 27.95% | 31.46% | 43.41% |
Return on invested capital | -1243.24% | 2.07% | 5.53% | 34.89% |
Profitability | 0% | 45% | 61% | 84% |
Total debt ratio | 29.55% | 91.02% | 90.77% | 24.67% |
Debt ratio change over time | -1.02% | 435.59% | 17.23% | -0.06% |
Dept financing | 8% | 50% | 26% | 7% |
Current Ratio | 1.64% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 1.41% | 0.31% | 0.49% | 2.77% |
Liquididy | 75% | 1% | 2% | 7% |
Short-term ratios | GNPX | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 5.91% |
Return on assets | -79.2% | 1.6% | 2.14% | 4.97% |
Return on sales | 0% | 24.8% | 18.91% | 42.59% |
Return on invested capital | 0% | 0% | 0% | 23.7% |
Profitability | 0% | 23% | 22% | 100% |
Total debt ratio | 43.85% | 94.49% | 93.35% | 24.56% |
Debt ratio change over time | -1.04% | 0% | 0% | -0.62% |
Dept financing | 12% | 25% | 50% | 6% |
Current Ratio | 1.64% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 1.41% | 0.31% | 0.49% | 2.77% |
Liquididy | 24% | 14% | 21% | 75% |